These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 2719341
1. Paroxysmal supraventricular tachycardia: experience with propafenone. Santinelli V, De Paola M, Turco P, Smimmo D, Chiariello M. Angiology; 1989 Jun; 40(6):563-8. PubMed ID: 2719341 [Abstract] [Full Text] [Related]
2. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia. Hammill SC, McLaran CJ, Wood DL, Osborn MJ, Gersh BJ, Holmes DR. J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724 [Abstract] [Full Text] [Related]
3. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation. Sethi KK, Prasad GS, Mohan JC, Arora R, Khalilullah M. Indian Heart J; 1991 Jun; 43(1):5-10. PubMed ID: 1894303 [Abstract] [Full Text] [Related]
4. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M, Steinbeck G, Lüderitz B. Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693 [Abstract] [Full Text] [Related]
5. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M, Cullen MT, Casadei G. Eur Heart J; 1995 Dec 01; 16(12):1943-51. PubMed ID: 8682031 [Abstract] [Full Text] [Related]
6. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Musto B, D'Onofrio A, Cavallaro C, Musto A. Circulation; 1988 Oct 01; 78(4):863-9. PubMed ID: 3168194 [Abstract] [Full Text] [Related]
7. [Electrophysiologic effects of intravenous propafenone]. Zhang S, Sun RL, Song YC. Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Jun 01; 17(3):133-6, 189. PubMed ID: 2598779 [Abstract] [Full Text] [Related]
8. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia]. Chachua T, Abuladze G, Nebieridze M. Georgian Med News; 2010 Jun 01; (183):18-21. PubMed ID: 20622270 [Abstract] [Full Text] [Related]
9. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Pritchett EL, McCarthy EA, Wilkinson WE. Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087 [Abstract] [Full Text] [Related]
10. Propafenone in Wolff-Parkinson-White syndrome at risk. Santinelli V, Turco P, De Paola M, Smimmo D, Giasi M, Santinelli C, Chiariello M, Condorelli M. Cardiovasc Drugs Ther; 1990 Jun 01; 4(3):681-5. PubMed ID: 2076378 [Abstract] [Full Text] [Related]
11. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M. Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994 [Abstract] [Full Text] [Related]
12. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?]. Inama G, Furlanello F, Braito G, Guarnerio M, Vergara G. G Ital Cardiol; 1991 Feb 20; 21(2):131-8. PubMed ID: 1907937 [Abstract] [Full Text] [Related]
13. [Electrophysiologic effect of intravenous propafenone in supraventricular tachycardia]. Iturralde P, Nunura F, Romero L, Colín L, Rosado J, Galván O, de Micheli A, González Hermosillo JA, Casanova JM. Arch Inst Cardiol Mex; 1991 Feb 20; 61(2):135-41. PubMed ID: 1854228 [Abstract] [Full Text] [Related]
14. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia]. Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS. Rev Port Cardiol; 1994 Mar 20; 13(3):197-202, 191. PubMed ID: 8049086 [Abstract] [Full Text] [Related]
15. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation]. Fauchier JP, Cosnay P, Moquet B, Rouesnel P, Kapusta P, Vrancea F. Arch Mal Coeur Vaiss; 1986 Sep 20; 79(10):1506-14. PubMed ID: 3099684 [Abstract] [Full Text] [Related]
16. The use of propafenone in the treatment of tachyarrhythmias in children. Vignati G, Mauri L, Figini A. Eur Heart J; 1993 Apr 20; 14(4):546-50. PubMed ID: 8472721 [Abstract] [Full Text] [Related]
17. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias. Rae AP. Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902 [Abstract] [Full Text] [Related]
18. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique]. Li Q, Wang Z, Peng D. Hunan Yi Ke Da Xue Xue Bao; 1997 Oct 16; 22(2):123-6. PubMed ID: 9868052 [Abstract] [Full Text] [Related]
19. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356 [Abstract] [Full Text] [Related]
20. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia. Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF. Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627 [Abstract] [Full Text] [Related] Page: [Next] [New Search]